152 related articles for article (PubMed ID: 32613686)
21. Proton pump inhibitor use represents an independent risk factor for myocardial infarction.
Shih CJ; Chen YT; Ou SM; Li SY; Chen TJ; Wang SJ
Int J Cardiol; 2014 Nov; 177(1):292-7. PubMed ID: 25499395
[TBL] [Abstract][Full Text] [Related]
22. Proton pump inhibitor use and risk of hip fracture in patients with type 2 diabetes.
Chou YS; Jiang HJ; Chen CH; Ho PS; Lee TC
Sci Rep; 2020 Aug; 10(1):14081. PubMed ID: 32826941
[TBL] [Abstract][Full Text] [Related]
23. Risk of gastric cancer among long-term proton pump inhibitor users: a population-based cohort study.
Kim JW; Jung HK; Lee B; Shin CM; Gong EJ; Hong J; Youn YH; Lee KJ
Eur J Clin Pharmacol; 2023 Dec; 79(12):1699-1708. PubMed ID: 37861752
[TBL] [Abstract][Full Text] [Related]
24. Association between use of proton pump inhibitors and occurrence of colon diverticulitis.
Ho BL; Hu HY; Chang SS
J Chin Med Assoc; 2016 Jan; 79(1):5-10. PubMed ID: 26404898
[TBL] [Abstract][Full Text] [Related]
25. Using proton pump inhibitors correlates with an increased risk of chronic kidney disease: a nationwide database-derived case-controlled study.
Hung SC; Liao KF; Hung HC; Lin CL; Lai SW; Lee PC; Hung SR
Fam Pract; 2018 Mar; 35(2):166-171. PubMed ID: 29045621
[TBL] [Abstract][Full Text] [Related]
26. Proton pump inhibitors use and the risk of fatty liver disease: A nationwide cohort study.
Pyo JH; Kim TJ; Lee H; Choi SC; Cho SJ; Choi YH; Min YW; Min BH; Lee JH; Kang M; Lee YC; Kim JJ
J Gastroenterol Hepatol; 2021 May; 36(5):1235-1243. PubMed ID: 32886822
[TBL] [Abstract][Full Text] [Related]
27. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
Lin SM; Yang SH; Liang CC; Huang HK
Osteoporos Int; 2018 Jan; 29(1):153-162. PubMed ID: 29032384
[TBL] [Abstract][Full Text] [Related]
28. Proton pump inhibitor use and hearing loss in patients with type 2 diabetes: Evidence from a hospital-based case-control study and a population-based cohort study.
Yee J; Han HW; Gwak HS
Br J Clin Pharmacol; 2022 Jun; 88(6):2738-2746. PubMed ID: 34970788
[TBL] [Abstract][Full Text] [Related]
29. Proton pump inhibitor use associated with an increased risk of gout: A population-based case-control study.
Zhu KJ; Feng W; Ma XN; Liao PL; Lin CS; Huang JY; Wei JC; Xu Q
Int J Rheum Dis; 2023 Sep; 26(9):1799-1806. PubMed ID: 37470673
[TBL] [Abstract][Full Text] [Related]
30. Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis.
De Roza MA; Kai L; Kam JW; Chan YH; Kwek A; Ang TL; Hsiang JC
World J Gastroenterol; 2019 Sep; 25(33):4933-4944. PubMed ID: 31543684
[TBL] [Abstract][Full Text] [Related]
31. The association between proton pump inhibitor use and the risk of tuberculosis: A case-control study.
Song HJ; Park H; Park S; Kwon JW
Pharmacoepidemiol Drug Saf; 2019 Jun; 28(6):830-839. PubMed ID: 30920070
[TBL] [Abstract][Full Text] [Related]
32. Association between recent use of proton pump inhibitors and nontyphoid salmonellosis: a nested case-control study.
Wu HH; Chen YT; Shih CJ; Lee YT; Kuo SC; Chen TL
Clin Infect Dis; 2014 Dec; 59(11):1554-8. PubMed ID: 25091310
[TBL] [Abstract][Full Text] [Related]
33. Potential risk of proton pump inhibitors for Parkinson's disease: A nationwide nested case-control study.
Hong JT; Jung HK; Lee KJ; Gong EJ; Shin CM; Kim JW; Youn YH; Lee B
PLoS One; 2023; 18(12):e0295981. PubMed ID: 38096177
[TBL] [Abstract][Full Text] [Related]
34. Association of Proton Pump Inhibitors Usage with Risk of Pneumonia in Dementia Patients.
Ho SW; Teng YH; Yang SF; Yeh HW; Wang YH; Chou MC; Yeh CB
J Am Geriatr Soc; 2017 Jul; 65(7):1441-1447. PubMed ID: 28321840
[TBL] [Abstract][Full Text] [Related]
35. Risk of inflammatory bowel disease in patients with rosacea: Results from a nationwide cohort study in Taiwan.
Wu CY; Chang YT; Juan CK; Shieh JJ; Lin YP; Liu HN; Lin JT; Chen YJ
J Am Acad Dermatol; 2017 May; 76(5):911-917. PubMed ID: 28073582
[TBL] [Abstract][Full Text] [Related]
36. Anticoagulant drugs with or without proton pump inhibitor and colorectal cancer risk: a population-based, case-control study.
Ho PH; Hsiao HC; Chen CW; Chen HM; Lim SN; Yeh CT; Kuo CJ; Lin WR
BMC Gastroenterol; 2022 May; 22(1):225. PubMed ID: 35534834
[TBL] [Abstract][Full Text] [Related]
37. Risk of psychiatric disorders in rosacea: A nationwide, population-based, cohort study in Taiwan.
Hung CT; Chiang CP; Chung CH; Tsao CH; Chien WC; Wang WM
J Dermatol; 2019 Feb; 46(2):110-116. PubMed ID: 30466187
[TBL] [Abstract][Full Text] [Related]
38. Increased risk of sleep disturbances in patients with rosacea: A nationwide population-based cohort study.
Chae K; Cho M; Kim S; Woo YR
J Dermatol; 2024 Jan; 51(1):70-75. PubMed ID: 37905567
[TBL] [Abstract][Full Text] [Related]
39. Proton Pump Inhibitors Increase the Risk of Autoimmune Diseases: A Nationwide Cohort Study.
Lin SH; Chang YS; Lin TM; Hu LF; Hou TY; Hsu HC; Shen YC; Kuo PI; Chen WS; Lin YC; Chen JH; Chang CC
Front Immunol; 2021; 12():736036. PubMed ID: 34659225
[TBL] [Abstract][Full Text] [Related]
40. Association between adherence to concomitant proton pump inhibitor therapy in current NSAID users and upper gastrointestinal complications.
Jonasson C; Hatlebakk JG; Lundell L; Kouri JP; Andersen M; Granath F
Eur J Gastroenterol Hepatol; 2013 May; 25(5):531-8. PubMed ID: 23269097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
